Wednesday, July 31, 2013

Merchant Law Group LLP is pursuing litigation concerning cellular phone use and brain tumours in Canada.


Merchant Law Group LLP is pursuing litigation concerning cellular phone use and brain tumours in Canada.

Excerpt from Merchant Law Group’s circulated flyer asking for participants in a class action:
Cell Phone Radiation Litigation
Merchant Law Group LLP is pursuing litigation concerning cellular phone use and brain tumours in Canada.
If you wish to receive updates about this action, particularly if you have used a cell phone and have been diagnosed with a brain tumour, please join the contact list by completing the form below. Please note that joining our contact list for the Cell Phone Litigation creates no financial obligation for you and your information will be kept confidential.
Merchant Law Group LLP has 12 offices across Canada, with lawyers practising law in six provinces. Merchant Law Group and Tony Merchant Q.C. are well known for pursuing class action lawsuits in Canada including litigation regarding Complete Contact Lens Solution,Winners/HomeSense, Various Cellular Phone Fees, BCE Dividends, GM Gasket Manifolds, Hip Implants, Lead Paint in Toys (and similar consumer products), Maple Leaf, Celebrex/Bextra, Vioxx, Sony, Residential Schools, Zonolite and various other cases. Tony Merchant is known to be one of Canada’s most active litigators with more than 600 reported cases in leading Caselaw Journals, having argued thousands of cases before the Canadian and American Courts, in Trial and Administrative Courts, and the Courts of Appeal of various American and Canadian jurisdictions, the Federal Court of Canada, and the Supreme Court of Canada. Tony Merchant, Q.C., has a long history in pursuing public policy cases and is a former Member of the Legislative Assembly (M.L.A.)
IF YOU WISH TO JOIN THIS CLASS ACTION OR TO SIMPLY GET MORE INFORMATION, PLEASE COMPLETE THE BELOW FORM
http://www.emfacts.com/2013/07/merchant-law-group-llp-is-pursuing-litigation-concerning-cellular-phone-use-and-brain-tumours-in-canada/

No comments:

Post a Comment